New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent (www.wired.com)

by rss-bot · 2 days ago · 0 comments
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.